ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 292 filers reported holding ICU MED INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,267,428 | -34.0% | 77,871 | -1.2% | 0.01% | -30.0% |
| Q2 2023 | $14,049,924 | +6.8% | 78,848 | -1.2% | 0.01% | +11.1% |
| Q1 2023 | $13,159,024 | +5.6% | 79,771 | +0.8% | 0.01% | 0.0% |
| Q4 2022 | $12,460,763 | +5.7% | 79,126 | +1.1% | 0.01% | 0.0% |
| Q3 2022 | $11,792,000 | -9.4% | 78,303 | -1.1% | 0.01% | -10.0% |
| Q2 2022 | $13,015,000 | -24.8% | 79,170 | +1.9% | 0.01% | -9.1% |
| Q1 2022 | $17,305,000 | -11.8% | 77,725 | -6.0% | 0.01% | -8.3% |
| Q4 2021 | $19,617,000 | +22.0% | 82,653 | +19.9% | 0.01% | +20.0% |
| Q3 2021 | $16,082,000 | +13.8% | 68,911 | +0.4% | 0.01% | +11.1% |
| Q2 2021 | $14,130,000 | +1.4% | 68,658 | +1.2% | 0.01% | -10.0% |
| Q1 2021 | $13,937,000 | +11.8% | 67,841 | +16.7% | 0.01% | +11.1% |
| Q4 2020 | $12,466,000 | +17.5% | 58,122 | +0.1% | 0.01% | 0.0% |
| Q3 2020 | $10,606,000 | -3.9% | 58,037 | -3.0% | 0.01% | -10.0% |
| Q2 2020 | $11,031,000 | -7.1% | 59,849 | +1.8% | 0.01% | -23.1% |
| Q1 2020 | $11,868,000 | -24.1% | 58,818 | -29.6% | 0.01% | 0.0% |
| Q4 2019 | $15,637,000 | +17.1% | 83,563 | -0.1% | 0.01% | +8.3% |
| Q3 2019 | $13,350,000 | -28.2% | 83,645 | +13.3% | 0.01% | -29.4% |
| Q2 2019 | $18,592,000 | +4.8% | 73,805 | -0.4% | 0.02% | 0.0% |
| Q1 2019 | $17,741,000 | +4.8% | 74,129 | +0.5% | 0.02% | -5.6% |
| Q4 2018 | $16,931,000 | -20.4% | 73,734 | -2.0% | 0.02% | -5.3% |
| Q3 2018 | $21,274,000 | +5.8% | 75,240 | +9.9% | 0.02% | +5.6% |
| Q2 2018 | $20,110,000 | +19.1% | 68,485 | +2.4% | 0.02% | +12.5% |
| Q1 2018 | $16,887,000 | -32.6% | 66,905 | -42.4% | 0.02% | -30.4% |
| Q4 2017 | $25,069,000 | +9.8% | 116,064 | -5.5% | 0.02% | +4.5% |
| Q3 2017 | $22,831,000 | -56.3% | 122,845 | -59.5% | 0.02% | -57.7% |
| Q2 2017 | $52,293,000 | +2.1% | 303,152 | -9.7% | 0.05% | -16.1% |
| Q1 2017 | $51,242,000 | +3.4% | 335,571 | -0.2% | 0.06% | -1.6% |
| Q4 2016 | $49,543,000 | +21.8% | 336,230 | +4.5% | 0.06% | +18.9% |
| Q3 2016 | $40,668,000 | +16.9% | 321,793 | +4.3% | 0.05% | +8.2% |
| Q2 2016 | $34,781,000 | +7.2% | 308,488 | -1.0% | 0.05% | +4.3% |
| Q1 2016 | $32,437,000 | +5.4% | 311,598 | +14.2% | 0.05% | +2.2% |
| Q4 2015 | $30,781,000 | +7.9% | 272,927 | +4.8% | 0.05% | +2.2% |
| Q3 2015 | $28,522,000 | +18.4% | 260,474 | +3.4% | 0.04% | +25.0% |
| Q2 2015 | $24,087,000 | +7.6% | 251,796 | +4.7% | 0.04% | +9.1% |
| Q1 2015 | $22,395,000 | +233.9% | 240,440 | +193.6% | 0.03% | +230.0% |
| Q4 2014 | $6,708,000 | +29.3% | 81,902 | +1.3% | 0.01% | +11.1% |
| Q3 2014 | $5,189,000 | +3.6% | 80,845 | -1.9% | 0.01% | +12.5% |
| Q2 2014 | $5,011,000 | -2.2% | 82,412 | -3.7% | 0.01% | -11.1% |
| Q1 2014 | $5,125,000 | -0.4% | 85,583 | +6.0% | 0.01% | -10.0% |
| Q4 2013 | $5,144,000 | +0.2% | 80,745 | +6.9% | 0.01% | -9.1% |
| Q3 2013 | $5,133,000 | -1.4% | 75,564 | +4.6% | 0.01% | -8.3% |
| Q2 2013 | $5,204,000 | – | 72,227 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |